WINDTREE THERAPEUTICS INC /DE/ Additional Paid in Capital, Common Stock
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Additional Paid in Capital, Common Stock of $616.25 million as of 2017-12-31, per its 10-K filed 2018-04-17.
Discontinued › Balance Sheet › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2018-04-17
- 2017-12-31: Additional Paid in Capital, Common Stock $616.25M.
- 2017-09-30: Additional Paid in Capital, Common Stock $605.18M.
- 2017-06-30: Additional Paid in Capital, Common Stock $605.00M.
- 2017-03-31: Additional Paid in Capital, Common Stock $604.68M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2017-12-31 | $616.25M 10-K · filed 2018-04-17 | |
| 2017-09-30 | $605.18M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $605.00M 10-Q · filed 2017-08-21 | |
| 2017-03-31 | $604.68M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $592.89M 10-K · filed 2018-04-17 | $592.88M 10-K · filed 2017-03-31 |
| 2016-09-30 | $592.26M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $591.53M 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $591.15M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $590.49M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $589.90M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $547.40M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $546.97M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $546.25M 10-K · filed 2016-03-29 | $546.17M 10-K · filed 2015-03-16 |
| 2014-09-30 | $545.31M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $544.22M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $543.20M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $541.42M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $476.69M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $475.81M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $459.84M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $455.40M 10-K · filed 2014-03-17 | |
| 2012-09-30 | $453.98M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $453.29M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $452.68M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $401.71M 10-K · filed 2013-03-15 | |
| 2011-09-30 | $400.88M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $400.61M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $385.52M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |